StudyTeam (Reify Health)

by OneStudyTeam (Reify Health)  · Based in United States →Empowering the Clinical Trials Ecosystem
Family Medicine Internal Medicine Oncology

Freemium (for sites), quote-based (for sponsors)
Regulatory Status Disclosed

Overview

Reify Health’s StudyTeam is a clinical trial enrollment platform designed to streamline patient screening and recruitment for research sites and physicians. The platform aims to remove operational bottlenecks in clinical trials, allowing new therapies to reach patients faster by improving the efficiency of the trial lifecycle.

StudyTeam connects research sites with sponsors, bringing the site’s workflow online and fostering seamless collaboration. This integration allows sites to more effectively pre-screen and enroll patients, while providing sponsors with real-time visibility into enrollment progress. This unprecedented clarity helps sponsors understand trial inputs and progress, saving time and improving predictability.

The platform was developed out of a recognition that traditional clinical trial stakeholders often work in silos, hindering efficient collaboration. By creating a common platform, StudyTeam enables sites, sponsors, and eventually other key players to work together toward the shared goal of assessing new therapies. This approach is critical for predictably enrolling clinical trials and delivering a high-quality patient experience.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Patient screening and recruitment management
  • Real-time enrollment visibility for sponsors
  • Site-sponsor workflow integration
  • Pre-screening tools
  • Enhanced collaboration across stakeholders
  • Data-driven enrollment insights

Use Cases

  • Accelerating clinical trial patient enrollment
  • Improving communication between research sites and sponsors
  • Streamlining patient pre-screening processes
  • Gaining real-time insights into trial progress
  • Reducing operational bottlenecks in clinical research

What Physicians Need to Know

Clinical Trial Matching
StudyTeam (part of OneStudyTeam, a Reify Health company) is a cloud-based platform that significantly accelerates patient recruitment and enrollment in clinical trials. It allows research sites to identify potential patients from their own practice and manage external referrals more effectively. The platform's 'Smart Patient Discovery' feature uses protocol information to suggest potential patients to research site coordinators, improving patient-to-trial matching.
Real-World Evidence Analysis
StudyTeam enables sponsors to gain insights into recruitment activity and enrollment trends in real-time. This visibility allows sponsors to identify pre-screen failure patterns across sites and consider updating inclusion/exclusion criteria to improve enrollment. While StudyTeam focuses on real-time clinical trial data, the broader industry is increasingly leveraging real-world data (RWD) for trial design optimization, site selection, and understanding treatment patterns.
Safety Signal Detection
StudyTeam's primary focus is on patient enrollment and recruitment management, not direct safety signal detection. However, by providing real-time visibility into enrollment and pre-screening data, it can indirectly help identify issues that might impact patient safety or trial integrity, such as unexpected pre-screen failure patterns. The broader field of drug development is utilizing AI-enabled platforms and real-world data for more proactive and scalable pharmacovigilance and safety signal detection.
Collaboration Features
StudyTeam acts as a common platform connecting research sites, sponsors, and other key stakeholders, enabling more effective collaboration. It facilitates real-time sharing of de-identified patient data and critical enrollment information between sites and sponsors, reducing manual work and improving communication.
Physician Tip

For physicians involved in clinical research, StudyTeam streamlines patient recruitment and enrollment by providing a centralized platform to manage patients across all trials and sponsors. Utilize the 'Smart Patient Discovery' feature to efficiently match patients from your practice to suitable trials. Leverage the real-time data and reporting to understand enrollment trends and identify potential roadblocks early, allowing for proactive adjustments to recruitment strategies. The platform's secure information sharing capabilities reduce administrative burden and enhance collaboration with sponsors. Actively use the diversity reporting features to ensure equitable representation in trials.

StudyTeam is designed to integrate seamlessly into existing site workflows, aiming to reduce the burden of managing multiple systems. It offers a Referral Partner Interface (RPI) to automatically import patient candidates from third-party recruitment partners directly into the system. The platform also supports calendar integration for scheduling and visit management. StudyTeam's architecture is built as a connected technology foundation to allow for additional functionality and integrations without creating significant additional work for users.

Details

Category Drug Discovery & Research
Pricing Freemium (for sites), quote-based (for sponsors)
  • StudyTeam for Sites is free for an unlimited number of users at a site, including access to features, live training, and ongoing support
  • For custom features or integrations, sites can contact OneStudyTeam
  • Pricing for sponsors is quote-based
Free TrialUnknown
DeploymentCloud-based
API AvailableUnknown
Data ExportUnknown
LanguagesAvailable in 15 languages for the platform, with training and course materials in 23 languages, including English, Spanish, Mandarin, Japanese, Korean, French, Italian, German, Bulgarian, Russian, and Portuguese.
TrainingUnknown
Target SizeAll types of research sites, including academic medical centers, hospital settings, private clinics, and independent research sites.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Not applicable AI-estimated — StudyTeam is GxP and 21 CFR Part 11 compliant.
GDPRUnknown AI-estimated
Integrations
EHR Not specified
Specialties Family Medicine, Internal Medicine, Oncology

Social Proof

CustomersOver 10,000 research sites.
Notable
AmgenAstraZenecaEli Lilly and CompanyMerckSanofiProKidney.

Support & Reliability

Training ProvidedUnknown

What the Web Says

StudyTeam by Reify Health is a cloud-based platform designed to streamline clinical trial workflows for both research sites and sponsors, aiming to accelerate the development of new therapies. It centralizes patient recruitment, pre-screening, and enrollment activities, reducing manual work and improving communication between sites and sponsors. The platform is widely praised for its user-friendliness and excellent customer support.

Overall: Positive

Strengths

  • Streamlines clinical trial management and improves team collaboration.
  • Centralizes information, making it easier to track patient data and study progress.
  • User-friendly interface and easy to navigate.
  • Provides real-time updates to sponsors, reducing the need for manual logs.
  • Helps sites pre-screen and enroll more patients, with some reporting over 15% more patients enrolled per month.
  • Free for research sites to use.

Limitations

  • Lack of certain customization options can hinder user experience.
  • Not all sponsors are linked to StudyTeam, limiting the platform's full advantages.
  • Cannot erase subjects when mistakes are made.
  • Difficulty in downloading a user-friendly calendar directly.
  • Some users find selecting patients in the Trial Board requires too many clicks.

Based on reviews from: G2, FeaturedCustomers, Capterra, OneStudyTeam (Reify Health website), Comparably

Last updated: 2026-09-11

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate StudyTeam (Reify Health)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Signalbase
Reify Health Raises $220M Series
Reify Health secured $220 million in Series D funding to accelerate its mission of making clinical trials faster, more predictable, and more accessible through its OneStudyTeam and Care Access entities. The company plans to deploy these funds to further develop its trial optimization software and enhance its clinical trial infrastructure.
2026-03
Business Wire
Reify Health Raises $220M Series D to Bridge the Diversity Gap in Clinical Trials
Reify Health announced a $220M Series D funding round, co-led by Altimeter Capital and Coatue, to accelerate efforts in improving diversity and representation in clinical trial participation. This funding brings the company's valuation to over $4.8 billion and supports its new BRIDGE initiative.
2022-04
Built In Boston
Boston-Based Reify Health Raises $220M, Doubles Valuation to $4.8B
Reify Health raised a $220 million Series D round, doubling its valuation to $4.8 billion, with plans to use the funding to increase diversity within clinical trial studies. The company is also launching a partner-backed initiative to understand barriers faced by marginalized communities in clinical trials.
2022-04
pharmaphorum
Financing pushes value of clinical trial tech firm Reify to $4.8bn
Reify Health completed a fourth-round financing of $220 million, increasing its valuation to $4.8 billion, with plans to launch a new initiative called BRIDGE to ensure clinical trials are inclusive and diverse. The BRIDGE program aims to understand and overcome reasons for underrepresentation in clinical research over the next decade.
2022-04
OneStudyTeam
Some Reify Health history and the Story of OneStudyTeam
Reify Health has been on a mission for over a decade to eliminate clinical trial operations as a bottleneck in delivering new therapies to patients. In 2015, Reify Health launched two initiatives: Care Access, which focuses on building new research sites in underserved communities, and StudyTeam, which aims to bring research site workflows online and connect stakeholders on a common platform.
2022-09
Endpoints News
Reify Health thinks clinical trials can be representative by 2030 u2014 and it's secured the capital to help partners put in the work
Reify Health believes clinical trials can achieve representation by 2030 and has secured $220 million in funding for its new initiative, BRIDGE (Bringing Representation, Inclusion and Diversity to Global Enrollment). This multi-year program will involve partnerships to tackle the complex problem of diversity in trials.
2022-04
Clinical Trials Arena
Reify Health secures $220m funding to improve clinical trial diversity
Reify Health secured $220 million in Series D funding to accelerate efforts in improving diversity and representation in clinical trials, bringing its valuation to over $4.8 billion. The company plans to launch the BRIDGE initiative to understand and overcome barriers for underrepresented minority groups in clinical trials.
2022-04
BioSpace
Reify Health Powers Patient Recruitment and Enrollment Across AstraZenecau2019s Extensive Breast Cancer Clinical Trial Pipeline
AstraZeneca selected Reify Health's StudyTeam platform to accelerate clinical development across its breast cancer investigational therapy portfolio. AstraZeneca has been deploying StudyTeam across multiple global oncology clinical trials since 2019, with sites using the platform randomizing more patients per site per month.
2021-04

Videos

Product demos, reviews, and walkthroughs for StudyTeam (Reify Health).

Loading videos...

View all on YouTube

Frequently Asked Questions

StudyTeam is a software platform designed to streamline patient enrollment in clinical trials. It helps sites manage patient pipelines, track screening and enrollment progress, and improve communication with sponsors, ultimately aiming to accelerate drug discovery research by optimizing patient recruitment.
StudyTeam incorporates features to support compliance, such as audit trails for patient interactions and data access controls. It's designed to help sites adhere to research protocols and maintain patient data privacy in accordance with regulations like HIPAA and GDPR, though specific compliance responsibilities remain with the research site.
Yes, there are other clinical trial management systems and patient recruitment platforms available. StudyTeam differentiates itself by focusing specifically on the patient enrollment workflow, offering real-time visibility into recruitment progress and facilitating collaboration between sites and sponsors.
Pricing for StudyTeam can vary depending on the size of the research site, the number of studies being managed, and the specific features required. It's generally structured as a subscription model, and sites would need to contact Reify Health directly for a detailed quote.
StudyTeam primarily focuses on patient enrollment and site-sponsor communication for recruitment. It does not typically encompass the full spectrum of drug discovery research, such as preclinical research, lab management, electronic data capture (EDC) for trial data beyond recruitment, or pharmacovigilance.
StudyTeam offers integration capabilities with various EHR systems to facilitate data exchange and reduce manual entry. The ease of integration can depend on the specific EHR system in use and the level of customization required, but Reify Health provides support for this process.
Yes, StudyTeam can assist in identifying potentially eligible patients by allowing sites to screen and track candidates from their own patient databases against study inclusion and exclusion criteria. This helps optimize the recruitment process by leveraging existing patient populations.

Related Tools

Noodle Biomedical Literature Discovery
Helena Bioinformatics
Drug Discovery & Research
Noodle is a biomedical literature discovery platform that allows researchers to search publications by meaning, inspect paper details, and explore related evidence through citation connections and semantic neighborhoods. It offers a public read-only Model Context Protocol (MCP) interface for AI agents.
Trially AI
Trially AI
Drug Discovery & Research
Trially's HIPAA-compliant AI platform matches, engages, and enrolls patients into trials with high accuracy, built for physicians and research sites.
Trial Library
Trial Library
Drug Discovery & Research
Trial Library's AI-native platform is embedded in community oncology practices to identify eligible patients for oncology clinical trials. It integrates clinical trials into routine care, activating providers, identifying eligible patients, and navigating them through the trial lifecycle across health systems, biopharma, and payers.
Mendel.ai
Mendel.ai
Clinical Decision Support & Reference
Mendel.ai uses Neuro-Symbolic AI to sort patient cohorts from EHRs for clinical trial matching, accelerating research.
Haystack Enroll
Haystack Health
Drug Discovery & Research
Haystack Health is a clinical trial platform that utilizes AI and care navigation to connect health plan members and ACO patients with relevant clinical trials, aiming to expand treatment access and improve outcomes.
Dyania Health Clinical Trial Recruitment
Dyania Health
Drug Discovery & Research
Dyania Health's AI-powered software automates patient identification from EHRs for clinical trial recruitment, serving hospitals, health systems, and pharmaceutical companies.

See all Drug Discovery & Research tools →

Suggest an Edit → | Last Verified: 2026-06-11 | First Added: 2026-06-11
AI Tool Finder
AI-powered search. Results may not be comprehensive.